Kit to evaluate the efficiency of tuberculosis treatment

Project 143

Problem to be solved:
• Adverse reactions induced by the isoniazid treatment
• Metabolic process of the drug related with adverse reactions

Proposed Innovation:
• To assess treatment’s efficiency
• Suitable therapy for each patient’s genotype

Differential:
• No similar product on national market
• Analysis of patients’ individual genotype
• Prediction of possible side effects
• Molecular diagnosis based on genetic polymorphism

Development status:
Laboratory

Intellectual property status:
BRPI0704093-8

What we want
Partnership

Coordinator:
Adalberto Rezende Santos / IOC

Contact:
Gestec/VPPIS – Phone: 21 3882-9099 / 3882-9120 or portfolio@fiocruz.br